The World of Health & Medicine News

Nature reduces pain-related brain activity

Nature reduces pain-related brain activity

Exposure to nature may change the way the brain responds to pain, according to a study by researchers at the Universities of Exeter and Vienna.

In this study, brain scans of 49 patients who received small electric shocks showed that pain-related activity was reduced when people were shown films with nature scenes compared to urban images or indoor office spaces.

Although nature’s effects on pain reduction are almost half that of painkillers, and the findings could provide alternative ways to manage pain, people with pain should definitely continue taking their prescribed medications, the researchers said./Nature Communications

spot_img

Explore more

spot_img

New lasso-shaped antibiotic kills drug-resistant bacteria

New lasso-shaped antibiotic kills drug-resistant bacteria Researchers at McMaster University have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including...

Chinese brain chip project speeds up human trials after first success

Chinese brain chip project speeds up human trials after first success A tie-up between a Chinese research institute and tech company said on Monday that...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by 94 percent According to results published in the New England Journal of Medicine: In a...

Novo Nordisk to license obesity drug from Lexicon in up to...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O),...

Vykat XR approved for genetic binge eating disorder

For the first time/ Vykat XR approved for genetic binge eating disorder The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics’ drug to...

Keytruda subcutaneous injection to launch on October 1

Keytruda subcutaneous injection to launch on October 1 Merck & Co. said Thursday it plans to launch a subcutaneous injection of its best-selling cancer immunotherapy,...

Buying an autoimmune disease drug for $1.3 billion

Sanofi/ Buying an autoimmune disease drug for $1.3 billion Sanofi announced Thursday that it has agreed to buy the biopharmaceutical company’s autoimmune disease drug Dren Bio...

US FDA approves Sanofi’s bleeding disorder therapy

US FDA approves Sanofi's bleeding disorder therapy The U.S. Food and Drug Administration approved French drugmaker Sanofi's (SASY.PA), opens new tab hemophilia therapy, introducing a new...